Enhanced 4-hydroxynonenal resistance in keap1 silenced human colon cancer cells

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Jung, Kyeong Ah ^a   Kwak, Mi Kyoung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4-HYDROXY-NONENAL; ADDUCT FORMATION; ALDO-KETO REDUCTASE; CELLULAR TOXICITIES; CONFORMATIONAL CHANGE; HUMAN COLON CANCER CELLS; NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2; TARGET GENE EXPRESSION;

CHEMICAL COMPOUNDS; CYTOLOGY; ENZYME ACTIVITY; GENES; PEROXIDES; TOXICITY; TRANSCRIPTION FACTORS;

CELLS;

4 HYDROXYNONENAL; ALDO KETO REDUCTASE 1B1; ALDO KETO REDUCTASE 1B10; ALDO KETO REDUCTASE 1C1; ALDO KETO REDUCTASE 1C2; ALDO KETO REDUCTASE 1C3; FLUFENAMIC ACID; HYDROGEN PEROXIDE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MESSENGER RNA; OXIDOREDUCTASE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; 4-HYDROXY-2-NONENAL; ALDEHYDE; ALDEHYDE REDUCTASE; CARBONYL REDUCTASE; KEAP1 PROTEIN, HUMAN; MENADIONE; SIGNAL PEPTIDE;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OXIDATIVE STRESS; PROTEIN EXPRESSION; CELL DEATH; CELL SURVIVAL; COLON TUMOR; DNA ADDUCT; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HCT116 CELL LINE; HEK293 CELL LINE; HT 29 CELL LINE; METABOLISM; PATHOLOGY;

ALDEHYDE REDUCTASE; ALDEHYDES; CELL DEATH; CELL SURVIVAL; COLONIC NEOPLASMS; DNA ADDUCTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HCT116 CELLS; HEK293 CELLS; HT29 CELLS; HUMANS; HYDROGEN PEROXIDE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; VITAMIN K 3;

EID: 84878692259     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/423965     Document Type: Article

References (64)

1. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., Nabeshima Y. I., An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochemical and Biophysical Research Communications 1997 236 2 313 322 2-s2.0-0031577292 10.1006/bbrc.1997.6943 (Pubitemid 27373291)
2. Kensler T. W., Wakabayashi N., Biswal S., Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annual Review of Pharmacology and Toxicology 2007 47 89 116 2-s2.0-33847050801 10.1146/annurev.pharmtox.46.120604.141046
3. Hayes J. D., McMahon M., NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends in Biochemical Sciences 2009 34 4 176 188 2-s2.0-63549121490 10.1016/j.tibs.2008.12.008
4. Jung K. A., Kwak M. K., The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules 2010 15 10 7266 7291 2-s2.0-78149434112 10.3390/molecules15107266
5. Li J., Johnson D., Calkins M., Wright L., Svendsen C., Johnson J., Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells. Toxicological Sciences 2005 83 2 313 328 2-s2.0-13644268144 10.1093/toxsci/kfi027 (Pubitemid 40227901)
6. Prawan A., Keum Y. S., Khor T. O., Yu S., Nair S., Li W., Hu L., Kong A. N., Structural influence of isothiocyanates on the antioxidant response element (ARE)-mediated heme oxygenase-1 (HO-1) expression. Pharmaceutical Research 2008 25 4 836 844 10.1007/s11095-007-9370-9 (Pubitemid 351661826)
7. Jung K. A., Choi B. H., Nam C. W., Song M., Kim S. T., Lee J. Y., Kwak M. K., Identification of aldo-keto reductases as NRF2-target marker genes in human cells. Toxicology Letters 2013 218 1 39 49 10.1016/j.toxlet.2012.12.026
8. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J. D., Yamamoto M., Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes and Development 1999 13 1 76 86 2-s2.0-0032953192 (Pubitemid 29045117)
9. Villeneuve N. F., Lau A., Zhang D. D., Regulation of the Nrf2-keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. Antioxidants and Redox Signaling 2010 13 11 1699 1712 2-s2.0-77958115724 10.1089/ars.2010.3211
10. Wakabayashi N., Slocum S. L., Skoko J. J., Shin S., Kensler T. W., When NRF2 talks, who's listening? Antioxidants and Redox Signaling 2010 13 11 1649 1663 2-s2.0-77956915802 10.1089/ars.2010.3216
11. Wakabayashi N., Itoh K., Wakabayashi J., Motohashi H., Noda S., Takahashi S., Imakado S., Kotsuji T., Otsuka F., Roop D. R., Harada T., Engel J. D., Yamamoto M., Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nature Genetics 2003 35 3 238 245 2-s2.0-0242329881 10.1038/ng1248 (Pubitemid 37363177)
12. Okawa H., Motohashi H., Kobayashi A., Aburatani H., Kensler T. W., Yamamoto M., Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochemical and Biophysical Research Communications 2006 339 1 79 88 2-s2.0-28144445947 10.1016/j.bbrc.2005.10.185 (Pubitemid 41697517)
13. Yates M. S., Tran Q. T., Dolan P. M., Osburn W. O., Shin S., McCulloch C. C., Silkworth J. B., Taguchi K., Yamamoto M., Williams C. R., Liby K. T., Sporn M. B., Sutter T. R., Kensler T. W., Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Carcinogenesis 2009 30 6 1024 1031 2-s2.0-66749112860 10.1093/carcin/bgp100
14. Devling T. W. P., Lindsay C. D., McLellan L. I., McMahon M., Hayes J. D., Utility of siRNA against Keap1 as a strategy to stimulate a cancer chemopreventive phenotype. Proceedings of the National Academy of Sciences of the United States of America 2005 102 20 7280 7285 2-s2.0-18844454763 10.1073/pnas.0501475102 (Pubitemid 40696370)
15. Agyeman A. S., Chaerkady R., Shaw P. G., Davidson N. E., Visvanathan K., Pandey A., Kensler T. W., Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles. Breast Cancer Research and Treatment 2012 132 1 175 187 2-s2.0-79955946590 10.1007/s10549-011-1536-9
16. Halliwell B., Chirico S., Lipid peroxidation: its mechanism, measurement, and significance. The American Journal of Clinical Nutrition 1993 57 5, supplement 715S 725S (Pubitemid 23141198)
17. Esterbauer H., Schaur R. J., Zollner H., Chemistry and Biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine 1991 11 1 81 128 2-s2.0-0025814980 10.1016/0891-5849(91)90192-6 (Pubitemid 121003917)
18. McGrath C. E., Tallman K. A., Porter N. A., Marnett L. J., Structure-activity analysis of diffusible lipid electrophiles associated with phospholipid peroxidation: 4-hydroxynonenal and 4-oxononenal analogues. Chemical Research in Toxicology 2011 24 3 357 370 2-s2.0-79952965423 10.1021/tx100323m
19. Uchida K., 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Progress in Lipid Research 2003 42 4 318 343 2-s2.0-0037411282 10.1016/S0163-7827(03)00014-6 (Pubitemid 36411689)
20. Butterfield D. A., Reed T., Sultana R., Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease. Free Radical Research 2011 45 1 59 72 2-s2.0-78650147789 10.3109/10715762.2010.520014
21. Karihtala P., Kauppila S., Puistola U., Jukkola-Vuorinen A., Divergent behaviour of oxidative stress markers 8-hydroxydeoxyguanosine (8-OHdG) and 4-hydroxy-2-nonenal (HNE) in breast carcinogenesis. Histopathology 2011 58 6 854 862 2-s2.0-79956122656 10.1111/j.1365-2559.2011.03835.x
22. Skrzydlewska E., Stankiewicz A., Sulkowska M., Sulkowski S., Kasacka I., Antioxidant status and lipid peroxidation in colorectal cancer. Journal of Toxicology and Environmental Health A 2001 64 3 213 222 2-s2.0-0035851008 10.1080/15287390152543690 (Pubitemid 32929955)
23. Burczynski M. E., Sridhar G. R., Palackal N. T., Penning T. M., The reactive oxygen species- and Michael acceptor-inducible human aldo-keto reductase AKR1C1 reduces the α β -unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihydroxy-2-nonene. The Journal of Biological Chemistry 2001 276 4 2890 2897 2-s2.0-0035951825 10.1074/jbc.M006655200
24. Malone P. E., Hernandez M. R., 4-Hydroxynonenal, a product of oxidative stress, leads to an antioxidant response in optic nerve head astrocytes. Experimental Eye Research 2007 84 3 444 454 2-s2.0-33846818874 10.1016/j.exer.2006.10.020 (Pubitemid 46210058)
25. Lyon R. C., Li D., McGarvie G., Ellis E. M., Aldo-keto reductases mediate constitutive and inducible protection against aldehyde toxicity in human neuroblastoma SH-SY5Y cells. Neurochemistry International 2013 62 1 113 121 10.1016/j.neuint.2012.10.007
26. Ramana K. V., Fadl A. A., Tammali R., Reddy A. B. M., Chopra A. K., Srivastava S. K., Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages. The Journal of Biological Chemistry 2006 281 44 33019 33029 2-s2.0-33845962827 10.1074/jbc.M603819200 (Pubitemid 46036684)
27. Bonnesen C., Eggleston I. M., Hayes J. D., Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Research 2001 61 16 6120 6130 2-s2.0-0035881570 (Pubitemid 32762548)
28. Matsunaga T., Yamane Y., Iida K., Endo S., Banno Y., El-Kabbani O., Hara A., Involvement of the aldo-keto reductase, AKR1B10, in mitomycin-c resistance through reactive oxygen species-dependent mechanisms. Anti-Cancer Drugs 2011 22 5 402 408 2-s2.0-79955051623 10.1097/CAD.0b013e3283448df0
29. Kim T. H., Hur E. G., Kang S. J., Kim J. A., Thapa D., Lee Y. M., Ku S. K., Jung Y., Kwak M. K., NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1 α Cancer Research 2011 71 6 2260 2275 10.1158/0008-5472.CAN-10-3007
30. Kwak M. K., Wakabayashi N., Itoh K., Motohashi H., Yamamoto M., Kensler T. W., Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway: identification of novel gene clusters for cell survival. The Journal of Biological Chemistry 2003 278 10 8135 8145 2-s2.0-0037424262 10.1074/jbc.M211898200 (Pubitemid 36800555)
31. Thimmulappa R. K., Mai K. H., Srisuma S., Kensler T. W., Yamamoto M., Biswal S., Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Research 2002 62 18 5196 5203 2-s2.0-0037106099 (Pubitemid 35033454)
32. Lee J. M., Calkins M. J., Chan K., Kan Y. W., Johnson J. A., Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. The Journal of Biological Chemistry 2003 278 14 12029 12038 2-s2.0-0038146898 10.1074/jbc.M211558200 (Pubitemid 36800179)
33. Kraft A. D., Johnson D. A., Johnson J. A., Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. Journal of Neuroscience 2004 24 5 1101 1112 2-s2.0-0842304134 10.1523/JNEUROSCI.3817-03.2004 (Pubitemid 38177017)
34. Higgins L. G., Kelleher M. O., Eggleston I. M., Itoh K., Yamamoto M., Hayes J. D., Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents. Toxicology and Applied Pharmacology 2009 237 3 267 280 2-s2.0-67349247003 10.1016/j.taap.2009.03.005
35. Liu D., el-Hariry I., Karayiannakis A. J., Wilding J., Chinery R., Kmiot W., McCrea P. D., Gullick W. J., Pignatelli M., Phosphorylation of β -catenin and epidermal growth factor receptor by intestinal trefoil factor. Laboratory Investigation 1997 77 6 557 563 (Pubitemid 28018775)
36. Rodrigues N. R., Rowan A., Smith M. E., Kerr I. B., Bodmer W. F., Gannon J. V., Lane D. P., p53 mutations in colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America 1990 87 19 7555 7559 10.1073/pnas.87.19.7555 (Pubitemid 20341755)
37. Redman C., Xu M. J., Peng Y. M., Scott J. A., Payne C., Clark L. C., Nelson M. A., Involvement of polyamines in selenomethionine induced apoptosis and mitotic alterations in human tumor cells. Carcinogenesis 1997 18 6 1195 1202 2-s2.0-0031417633 10.1093/carcin/18.6.1195 (Pubitemid 28132511)
38. Lorentz O., Cadoret A., Duluc I., Capeau J., Gespach C., Cherqui G., Freund J. N., Downregulation of the colon tumour-suppressor homeobox gene Cdx-2 by oncogenic ras. Oncogene 1999 18 1 87 92 2-s2.0-0033531262 10.1038/sj.onc.1202280 (Pubitemid 29060582)
39. Ilyas M., Tomlinson I. P. M., Rowan A., Pignatelli M., Bodmer W. F., β -catenin mutations in cell lines established from human colorectal cancers. Proceedings of the National Academy of Sciences of the United States of America 1997 94 19 10330 10334 2-s2.0-0030923587 10.1073/pnas.94.19.10330 (Pubitemid 27407041)
40. Schroy 3rd P. C., Brown-Shimer S., Kim K., Johnson K. A., Murnane M. J., Yang S., O'Brien M. J., Carney W. P., Kupchik H. Z., Detection of p21ras mutations in colorectal adenomas and carcinomas by enzyme-linked immunosorbent assay. Cancer 1995 76 2 201 209
41. Groden J., Joslyn G., Samowitz W., Jones D., Bhattacharyya N., Spirio L., Thliveris A., Robertson M., Egan S., Meuth M., White R., Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene. Cancer Research 1995 55 7 1531 1539 2-s2.0-0028941969
42. Narayan S., Jaiswal A. S., Activation of adenomatous polyposis coli (APC) gene expression by the DNA-alkylating agent N-methyl-N′-nitro-N- nitrosoguanidine requires p53. The Journal of Biological Chemistry 1997 272 49 30619 30622 2-s2.0-0030722195 10.1074/jbc.272.49.30619 (Pubitemid 27527492)
43. Zhang L., Yu J., Park B. H., Kinzler K. W., Vogelstein B., Role of BAX in the apoptotic response to anticancer agents. Science 2000 290 5493 989 992 2-s2.0-0034602188 10.1126/science.290.5493.989
44. Jin Y., Penning T. M., Aldo-keto reductases and bioactivation/ detoxication. Annual Review of Pharmacology and Toxicology 2007 47 263 292 10.1146/annurev.pharmtox.47.120505.105337
45. Higaki Y., Usami N., Shintani S., Ishikura S., El-Kabbani O., Hara A., Selective and potent inhibitors of human 20 α -hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone. Chemico-Biological Interactions 2003 143-144 503 513 2-s2.0-0037324845 10.1016/S0009-2797(02)00206-5 (Pubitemid 36253599)
46. Steckelbroeck S., Oyesanmi B., Jin Y., Lee S. H., Kloosterboer H. J., Penning T. M., Tibolone metabolism in human liver is catalyzed by 3 α /3 β -hydroxysteroid dehydrogenase activities of the four isoforms of the aldo-keto reductase (AKR)1C subfamily. Journal of Pharmacology and Experimental Therapeutics 2006 316 3 1300 1309 2-s2.0-33644749351 10.1124/jpet.105.091587 (Pubitemid 43345306)
47. Ruiz F. X., Porté S., Gallego O., Moro A., Ardèvol A., Del Río-Espínola A., Rovira C., Farrés J., Parés X., Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. Biochemical Journal 2011 440 3 335 344 10.1042/BJ20111286
48. Reisman S. A., Yeager R. L., Yamamoto M., Klaassen C. D., Increased Nrf2 activation in livers from keap1-knockdown mice Increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species. Toxicological Sciences 2009 108 1 35 47 2-s2.0-61349117533 10.1093/toxsci/kfn267
49. Itoh K., Mimura J., Yamamoto M., Discovery of the negative regulator of Nrf2, keap1: a historical overview. Antioxidants and Redox Signaling 2010 13 11 1665 1678 2-s2.0-77958125017 10.1089/ars.2010.3222
50. Dinkova-Kostova A. T., Holtzclaw W. D., Cole R. N., Itoh K., Wakabayashi N., Katoh Y., Yamamoto M., Talalay P., Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proceedings of the National Academy of Sciences of the United States of America, 2002 99 18 11908 11913 (Pubitemid 34994497)
51. Wakabayashi N., Dinkova-Kostova A. T., Holtzclaw W. D., Kang M. I., Kobayashi A., Yamamoto M., Kensler T. W., Talalay P., Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proceedings of the National Academy of Sciences of the United States of America 2004 101 7 2040 2045 2-s2.0-1242296811 10.1073/pnas.0307301101 (Pubitemid 38229011)
52. Zhang D. D., Hannink M., Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Molecular and Cellular Biology 2003 23 22 8137 8151 2-s2.0-0242580049 10.1128/MCB.23.22.8137-8151.2003 (Pubitemid 37377505)
53. Eggler A. L., Liu G., Pezzuto J. M., van Breemen R. B., Mesecar A. D., Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proceedings of the National Academy of Sciences of the United States of America 2005 102 29 10070 10075 2-s2.0-22544464124 10.1073/pnas.0502402102 (Pubitemid 41023327)
54. Eggler A. L., Luo Y., van Breemen R. B., Mesecar A. D., Identification of the highly reactive cysteine 151 in the chemopreventive agent-sensor Keap1 protein is method-dependent. Chemical Research in Toxicology 2007 20 12 1878 1884 2-s2.0-36349019109 10.1021/tx700217c
55. Mindnich R. D., Penning T. M., Aldo-keto reductase (AKR) superfamily: genomics and annotation. Human Genomics 2009 3 4 362 370 2-s2.0-70350787143
56. Byrns M. C., Penning T. M., Type 5 17 β -hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs. Chemico-Biological Interactions 2009 178 1-3 221 227 2-s2.0-59049089110 10.1016/j.cbi.2008.10.024
57. Penning T. M., Drury J. E., Human aldo-keto reductases: function, gene regulation, and single nucleotide polymorphisms. Archives of Biochemistry and Biophysics 2007 464 2 241 250 2-s2.0-34547692874 10.1016/j.abb.2007.04.024 (Pubitemid 47214569)
58. Vondracek J., Krcmar P., Prochazkova J., The role of aryl hydrocarbon receptor in regulation of enzymes involved in metabolic activation of polycyclic aromatic hydrocarbons in a model of rat liver progenitor cells. Chemico-Biological Interactions 2009 180 2 226 237 10.1016/j.cbi.2009.03.011
59. Lou H., Du S., Ji Q., Stolz A., Induction of AKR1C2 by phase II inducers: identification of a distal consensus antioxidant response element regulated by NRF2. Molecular Pharmacology 2006 69 5 1662 1672 2-s2.0-33645893202 10.1124/mol.105.019794
60. Macleod A. K., Mcmahon M., Plummer S. M., Higgins L. G., Penning T. M., Igarashi K., Hayes J. D., Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds. Carcinogenesis 2009 30 9 1571 1580 2-s2.0-70249138697 10.1093/carcin/bgp176
61. Pettazzoni P., Ciamporcero E., Medana C., Pizzimenti S., Dal Bello F., Minero V. G., Toaldo C., Minelli R., Uchida K., Dianzani M. U., Pili R., Barrera G., Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells. Free Radical Biology and Medicine 2011 51 8 1610 1618 10.1016/j.freeradbiomed.2011.07.009
62. Miller D. M., Singh I. N., Wang J. A., Hall E. D., Administration of the Nrf2-ARE activators sulforaphane and carnosic acid attenuates 4-hydroxy-2-nonenal-induced mitochondrial dysfunction ex vivo. Free Radical Biology and Medicine 2012 57 1 9 10.1016/j.freeradbiomed.2012.12.011
63. Ramana K. V., Dixit B. L., Srivastava S., Balendiran G. K., Srivastava S. K., Bhatnagar A., Selective recognition of glutathiolated aldehydes by aldose reductase. Biochemistry 2000 39 40 12172 12180 2-s2.0-0034633980 10.1021/bi000796e
64. Feng Z., Hu W., Tang M. S., Trans-4-hydroxy-2-nonenial inhibits nucleotide excision repair human cells: a possible mechanism for lipid peroxidation-induced carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America 2004 101 23 8598 8602 2-s2.0-2942567694 10.1073/pnas.0402794101 (Pubitemid 38745816)